{
  "id": 20916677,
  "title": "Merck gets another Phase 3 win for sac-TMT, this time in gastric cancer",
  "url": "https://urgent.news/2026/11/20/merck-gets-another-phase-3-win-for-sac-tmt-this-time-in-gastric-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-20T15:31:58.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/merck-gets-another-phase-3-win-for-sac-tmt-this-time-in-gastric-cancer/"
  },
  "original_language": "en",
  "account": null,
  "summary": "An experimental antibody-drug conjugate from Merck has succeeded in another Phase 3 cancer study, potentially helping offset Keytruda's looming patent cliff. Merck said Friday morning that a pivotal trial testing sacituzumab ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}